モリモト　サトシ   MORIMOTO Satoshi   森本　聡    所属   医学部 医学科（東京女子医科大学病院）    職種   准教授
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.
掲載誌名	正式名：Journal of pharmacological sciences 略　 称：J Pharmacol Sci ISSNコード：1347-8648(Electronic)1347-8613(Linking)
巻・号・頁	122(2),pp.103-8
著者・共著者	OHNISHI Keisuke†, MURASE Miki, NAKANO Daisuke, PELISCH Nicolas, HITOMI Hirofumi, KOBORI Hiroyuki, MORIMOTO Satoshi, MORI Hirohito, MASAKI Tsutomu, OHMORI Koji, KOHNO Masakazu, ICHIHARA Atsuhiro, NISHIYAMA Akira
発行年月	2013/06
概要	Angiotensin II (Ang II) infusion into rats elevates local angiotensin II levels through an AT1 receptor-dependent pathway in the kidney. We examined whether treatment with an angiotensin-converting enzyme (ACE) inhibitor, temocapril, or an AT1-receptor blocker, olmesartan, prevented elevation of Ang II levels in the kidney of angiotensin I (Ang I)-infused rats. Rats were infused with Ang I (100 ng/min) and treated with temocapril (30 mg/kg per day, n = 10) or olmesartan (10 mg/kg per day, n = 9) for 4 weeks. Ang I infusion significantly elevated blood pressure compared with vehicle-infused rats (n = 6). Treatment with temocapril or olmesartan suppressed Ang I-induced hypertension. Temocapril suppressed both plasma and renal ACE activity. Ang I infusion increased Ang II content in the kidney. Interestingly, temocapril failed to reduce the level of Ang II in the kidney, while olmesartan markedly suppressed an increase in renal Ang II levels. These results suggest a limitation of temocapril and a benefit of olmesartan to inhibit the renal renin-angiotensin system and suggest the possible existence of an ACE inhibitor-insensitive pathway that increases Ang II levels in rat kidney.
文献番号	23698111